337 results on '"Sanz-Pamplona, Rebeca"'
Search Results
2. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe
3. Germline genetic regulation of the colorectal tumor immune microenvironment
4. Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
5. MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer
6. CAR Immunotherapy for the treatment of infectious diseases: a systematic review
7. Unraveling the Power of NAP-CNB’s Machine Learning-enhanced Tumor Neoantigen Prediction
8. Author response: Unraveling the Power of NAP-CNB’s Machine Learning-enhanced Tumor Neoantigen Prediction
9. Post-polypectomy colonoscopy surveillance: Can we improve the diagnostic yield?
10. Solving the enigma of POLD1 p.V295M as a potential cause of increased cancer risk
11. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA
12. Author Correction: COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients
13. COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients
14. Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer.
15. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe
16. Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
17. Algorithmic Methods to Infer the Evolutionary Trajectories in Cancer Progression
18. Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.
19. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
20. CAR Immunotherapy for the treatment of infectious diseases: a systematic review
21. Role of POLE and POLD1 in familial cancer
22. Identifying causal models between genetically regulated methylation patterns and gene expression in healthy colon tissue
23. Predicting MHC I restricted T cell epitopes in mice with NAP-CNB, a novel online tool
24. Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction
25. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer
26. Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients
27. Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response
28. Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer
29. Molecular approaches for classifying endometrial carcinoma
30. Supplementary material for Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes [Dataset]
31. Adoptive NK cell transfer as a treatment in colorectal cancer patients: analyses of tumour cell determinants correlating with efficacy in vitro and in vivo
32. Colon-specific eQTL analysis to inform on functional SNPs
33. Supplementary Figure from A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β
34. Abstract 5105: TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis
35. Data from A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β
36. Supplementary Figure 4 from Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer
37. Supplementary Table 1 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
38. supplementary material legends from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
39. Supplementary Table 5 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
40. Supplementary Table 2 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
41. Supplementary Table 8 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
42. Supplementary Table 7 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
43. Data from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
44. Supplementary Table 3 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
45. Supplementary Methods, Tables 1-4, Figures 1-7 from Gene Expression Differences between Colon and Rectum Tumors
46. Supplementary Table 4 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
47. Supplementary Table 6 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
48. Supplementary Figures from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
49. Extranodal natural killer/T‐cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
50. Algorithmic methods to infer the evolutionary trajectories in cancer progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.